Tristel PLC (GB:TSTL)

LSE:TSTL

TSTL

Tristel

RESEARCH TOOLSreports

Want to see GB:TSTL full AI Analyst Report?

Tristel (TSTL) Price & Analysis

17 Followers

TSTL Stock Chart & Stats

425.00 p

2.50 p(0.59%)

At close: Jan 09 4:00 PM EST

425.00 p

2.50 p(0.59%)

Day’s Range― - ―

52-Week Range340.00 p - 445.00 p

Previous CloseN/A

Volume2.07K

Average Volume (3M)75.90K

Market Cap

£189.55M

Enterprise Value188.17M

Total Cash (Recent Filing)£13.29M

Total Debt (Recent Filing)£5.82M

Price to Earnings (P/E)12.6

Beta0.72

Next Earnings

Oct 19, 2026

EPS Estimate

0.09

Next Dividend Ex-DateN/A

Dividend Yield3.48%

Share Statistics

EPS (TTM)0.16

Shares Outstanding47,986,294

10 Day Avg. Volume83,961

30 Day Avg. Volume75,902

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)5.93

Price to Sales (P/S)4.21

P/FCF Ratio20.67

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.17

Revenue Forecast (FY)£51.18M

Bulls Say, Bears Say

Bulls Say

High Gross & EBITDA MarginsSustained high gross margins (~81.6%) and a 29% adjusted EBITDA margin reflect durable pricing power from proprietary chlorine dioxide chemistry and efficient operations. This margin base supports reinvestment, dividend policy and buffers against cyclical volume swings over a multi‑year horizon.

Recurring Consumables & Regulatory ValidationRevenue is anchored in repeat‑purchase consumables and validated infection‑control processes, creating predictable, recurring demand. Clinical guideline inclusions and compatibility with >1,200 probes increase switching costs and long‑term adoption across hospital departments and geographies.

Strong Balance Sheet And Cash GenerationA debt‑free balance sheet with robust cash balances and strong operating cash generation provides financial flexibility to fund U.S. commercial rollouts, clinical studies, and insourcing investments without undue leverage, supporting medium‑term growth and progressive dividends.

Bears Say

Free Cash Flow Growth DeclineA 12.7% decline in free cash flow growth signals early softening in cash conversion that could constrain discretionary spending, dividend increases or acquisitions if it persists. Monitoring is needed to ensure investment and dividend plans remain sustainable over the medium term.

China / APAC Market WeaknessMaterial weakness in China/APAC exposes Tristel to regional demand volatility and policy risk. Reliance on recovering emerging markets could slow aggregate revenue growth and require reallocation of commercial resources or pricing adjustments to offset prolonged regional headwinds.

Margin Pressure From Insourcing & Higher Operating SpendInsourcing wipes and associated asset costs, plus a one‑off GBP 300k write‑off and higher S&M and hiring, raise fixed cost and execution risk. If scale benefits are delayed, these structural cost increases could compress margins and slow target EBITDA delivery in the medium term.

Tristel News

Tristel Increases Share Capital After Employee Option Exercise

Tristel ( ($GB:TSTL) ) just unveiled an update. Tristel plc, the AIM‑quoted manufacturer of infection prevention products for...

8d ago

Tristel Updates Share Capital After Employee Option Exercise

Tristel ( ($GB:TSTL) ) has issued an announcement. Tristel has issued and allotted 20,000 new ordinary shares following...

16d ago

Artemis Takes 3% Stake in Infection Prevention Group Tristel

Tristel ( ($GB:TSTL) ) just unveiled an announcement. Tristel plc, a UK-based infection prevention specialist, develops and manufactures...

1M ago

Tristel Non-Executive Director Increases Stake in Infection Prevention Group

An update from Tristel ( ($GB:TSTL) ) is now available. Tristel plc, the AIM-listed infection prevention specialist, has...

2M ago

Tristel to Outline Strategy at ShareSoc Growth Event in Leeds

An announcement from Tristel ( ($GB:TSTL) ) is now available. Tristel plc, the AIM-listed infection prevention company headquartered...

2M ago

Tristel plc Earnings Call Highlights Growth Momentum

Tristel plc (($GB:TSTL)) has held its Q2 earnings call. Read on for the main highlights of the call....

3M ago

Tristel Director’s Associate Increases Stake in Infection Prevention Specialist

Tristel ( ($GB:TSTL) ) has issued an update. Tristel plc, the AIM‑quoted infection prevention specialist, develops chlorine dioxide‑based...

3M ago

Tristel Delivers Double-Digit Growth as US Business Surges and Product Portfolio Expands

The latest announcement is out from Tristel ( ($GB:TSTL) ). Tristel reported a strong first half to 31...

3M ago

Tristel Issues New Shares Following Employee Option Exercise

Tristel ( ($GB:TSTL) ) has issued an update. Tristel plc, the AIM-listed infection prevention specialist focused on chlorine...

3M ago

Tristel Issues New Shares After Employee Option Exercise

Tristel ( ($GB:TSTL) ) has shared an announcement. Tristel plc has issued and allotted 71,500 new ordinary shares...

3M ago

TSTL FAQ

What was Tristel PLC’s price range in the past 12 months?

Tristel PLC lowest share price was 340.00 p and its highest was 445.00 p in the past 12 months.

What is Tristel PLC’s market cap?

Tristel PLC’s market cap is £189.55M.

When is Tristel PLC’s upcoming earnings report date?

Tristel PLC’s upcoming earnings report date is Oct 19, 2026 which is in 152 days.

How were Tristel PLC’s earnings last quarter?

Tristel PLC released its earnings results on Mar 02, 2026. The company reported 0.094 p earnings per share for the quarter, beating the consensus estimate of 0.092 p by 0.002 p.

Is Tristel PLC overvalued?

According to Wall Street analysts Tristel PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Tristel PLC pay dividends?

Tristel PLC pays a Semiannually dividend of 8.52 p which represents an annual dividend yield of 3.48%. See more information on Tristel PLC dividends here

What is Tristel PLC’s EPS estimate?

Tristel PLC’s EPS estimate is 0.09.

How many shares outstanding does Tristel PLC have?

Tristel PLC has 47,986,294 shares outstanding.

What happened to Tristel PLC’s price movement after its last earnings report?

Tristel PLC reported an EPS of 0.094 p in its last earnings report, beating expectations of 0.092 p. Following the earnings report the stock price went down -0.75%.

Which hedge fund is a major shareholder of Tristel PLC?

Currently, no hedge funds are holding shares in GB:TSTL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Tristel Stock Smart Score

Neutral

Fundamentals

Return on Equity

23.64%

Trailing 12-Months

Asset Growth

6.03%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Tristel PLC

Tristel plc (TSTL) is a UK-based company that specializes in infection prevention and control, primarily serving the healthcare sector. The company focuses on developing and manufacturing infection control products, particularly in the areas of surface disinfection and medical device decontamination. Tristel's core offerings include its proprietary chlorine dioxide-based disinfectant products, which are designed to provide effective and safe disinfection solutions across various healthcare environments.